Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05636098 · ClinicalTrials.gov registry record · NA
Repeatability and Reproducibility of Oxygen Reserve Index (ORi)
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT05636098 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 53 participants.
The verdict
NCT05636098, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
This study is designed to evaluate the repeatability and reproducibility of ORi using an investigational Masimo rainbow sensor and FDA cleared rainbow sensors connected to the Masimo Radical-7 pulse oximeter and Masimo Root monitor in healthy volunteers as the subjects undergo a controlled hyperoxygenation protocol.
Interventions
- DEVICE Masimo Rainbow Sensors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2023-01-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05636098
The ClinicalTrials.gov registry entry for NCT05636098 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Masimo Rainbow Sensors is the first listed.
NCT05636098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05636098 about?
NCT05636098 is a clinical study titled "Repeatability and Reproducibility of Oxygen Reserve Index (ORi)". This study is designed to evaluate the repeatability and reproducibility of ORi using an investigational Masimo rainbow sensor and FDA cleared rainbow sensors connected to the Masimo Radical-7 pulse oximeter and Masimo Root monitor in healthy volunteers as the subjects undergo a controlled hyperoxyg...
What is the current status of trial NCT05636098?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2022-11-07. Estimated completion is 2023-01-11.
What interventions are being tested in trial NCT05636098?
The interventions under investigation include: Masimo Rainbow Sensors (DEVICE).
Who is sponsoring clinical trial NCT05636098?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.